Zoom conference call scheduled for 9:00 AM ET
REHOVOT, Israel, May 9, 2024
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a
leading computational biology company targeting to revolutionize
life-science product discovery and development, announced today
that it will release its financial results for the first quarter of
2024, on Thursday, May 23,
2024.
Later that day, Company management will host a conference
call to discuss the results at 9:00 AM
Eastern Time (4:00 PM
Israel time).
To join the conference, please register in advance:
https://us06web.zoom.us/webinar/register/WN_GBxR-LTZRYy9D7OIt2YW0g
The entire conference will be available online on the company's
website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational
biology company leveraging big data and artificial
intelligence, aiming to revolutionize the development of
life-science-based products by utilizing cutting-edge technologies
to increase the probability of success while reducing development
time and cost.
Evogene established three unique tech-engines -
MicroBoost AI, ChemPass
AI and GeneRator AI. Each tech-engine is
focused on the discovery and development of products based on one
of the following core components: microbes (MicroBoost AI),
small molecules (ChemPass AI), and genetic elements
(GeneRator AI).
Evogene uses its tech-engines to develop products through
strategic partnerships and collaborations, and its four
subsidiaries including:
- Biomica Ltd. (www.biomicamed.com) - developing
and advancing novel microbiome-based therapeutics to treat human
disorders powered by MicroBoost AI;
- Lavie Bio
Ltd. (www.lavie-bio.com)
- developing and commercially advancing,
microbiome-based ag-biologicals powered
by MicroBoost AI;
- AgPlenus Ltd. (www.agplenus.com)
- developing next-generation ag chemicals for
effective and sustainable crop protection powered
by ChemPass AI;
- Casterra Ag
Ltd. (www.casterra.co) - developing
and marketing superior castor seed varieties producing high yield
and high-grade oil content on an industrial scale for the
biofuel and other industries powered
by GeneRator AI.
For more information, please visit: www.evogene.com.
Contacts
Rachel Pomerantz
Gerber
Head of Investor Relations at Evogene
rachel.pomerantz@evogene.com
Tel: +972-8-9311901
Logo:
https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/evogene-schedules-first-quarter-2024-financial-results-release-302141103.html
SOURCE Evogene